The emerging crisis of drug-resistant tuberculosis in South Africa: Lessons from New York City

Richard A. Murphy

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis have emerged as important infections in South Africa among patients infected with human immunodeficiency virus (HIV). In the face of this new epidemic, South Africa must rededicate itself to the task of tuberculosis control and treatment with a rapid, multifaceted approach. Priorities include expansion of second-line treatment capacity, investment in clinical laboratories, a system to ensure supervised treatment for all patients, and enhancement of infection control procedures. In New York City, where drug-resistant tuberculosis emerged 2 decades ago - also in the context of a large HIV-infected population and an underfunded public health infrastructure - similar steps were successful in leading to the rapid decrease in rates of drug resistance among tuberculosis isolates. With refinements based on local resource constraints, urgent measures could potentially arrest the alarming increase in multidrug-resistant and extensively drug-resistant tuberculosis cases in South Africa. Unlike many countries in sub-Saharan Africa, South Africa has the capacity to mount a rapid and large-scale response before drug-resistant tuberculosis envelops a much larger and far poorer region.

Original languageEnglish (US)
Pages (from-to)1729-1732
Number of pages4
JournalClinical Infectious Diseases
Volume46
Issue number11
DOIs
StatePublished - Jun 1 2008
Externally publishedYes

Fingerprint

Multidrug-Resistant Tuberculosis
South Africa
Extensively Drug-Resistant Tuberculosis
Tuberculosis
HIV
Africa South of the Sahara
Infection Control
Drug Resistance
Therapeutics
Public Health
Infection
Population

ASJC Scopus subject areas

  • Immunology

Cite this

The emerging crisis of drug-resistant tuberculosis in South Africa : Lessons from New York City. / Murphy, Richard A.

In: Clinical Infectious Diseases, Vol. 46, No. 11, 01.06.2008, p. 1729-1732.

Research output: Contribution to journalArticle

@article{bd32025f8e1849889d72cc05338ae958,
title = "The emerging crisis of drug-resistant tuberculosis in South Africa: Lessons from New York City",
abstract = "Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis have emerged as important infections in South Africa among patients infected with human immunodeficiency virus (HIV). In the face of this new epidemic, South Africa must rededicate itself to the task of tuberculosis control and treatment with a rapid, multifaceted approach. Priorities include expansion of second-line treatment capacity, investment in clinical laboratories, a system to ensure supervised treatment for all patients, and enhancement of infection control procedures. In New York City, where drug-resistant tuberculosis emerged 2 decades ago - also in the context of a large HIV-infected population and an underfunded public health infrastructure - similar steps were successful in leading to the rapid decrease in rates of drug resistance among tuberculosis isolates. With refinements based on local resource constraints, urgent measures could potentially arrest the alarming increase in multidrug-resistant and extensively drug-resistant tuberculosis cases in South Africa. Unlike many countries in sub-Saharan Africa, South Africa has the capacity to mount a rapid and large-scale response before drug-resistant tuberculosis envelops a much larger and far poorer region.",
author = "Murphy, {Richard A.}",
year = "2008",
month = "6",
day = "1",
doi = "10.1086/587903",
language = "English (US)",
volume = "46",
pages = "1729--1732",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - The emerging crisis of drug-resistant tuberculosis in South Africa

T2 - Lessons from New York City

AU - Murphy, Richard A.

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis have emerged as important infections in South Africa among patients infected with human immunodeficiency virus (HIV). In the face of this new epidemic, South Africa must rededicate itself to the task of tuberculosis control and treatment with a rapid, multifaceted approach. Priorities include expansion of second-line treatment capacity, investment in clinical laboratories, a system to ensure supervised treatment for all patients, and enhancement of infection control procedures. In New York City, where drug-resistant tuberculosis emerged 2 decades ago - also in the context of a large HIV-infected population and an underfunded public health infrastructure - similar steps were successful in leading to the rapid decrease in rates of drug resistance among tuberculosis isolates. With refinements based on local resource constraints, urgent measures could potentially arrest the alarming increase in multidrug-resistant and extensively drug-resistant tuberculosis cases in South Africa. Unlike many countries in sub-Saharan Africa, South Africa has the capacity to mount a rapid and large-scale response before drug-resistant tuberculosis envelops a much larger and far poorer region.

AB - Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis have emerged as important infections in South Africa among patients infected with human immunodeficiency virus (HIV). In the face of this new epidemic, South Africa must rededicate itself to the task of tuberculosis control and treatment with a rapid, multifaceted approach. Priorities include expansion of second-line treatment capacity, investment in clinical laboratories, a system to ensure supervised treatment for all patients, and enhancement of infection control procedures. In New York City, where drug-resistant tuberculosis emerged 2 decades ago - also in the context of a large HIV-infected population and an underfunded public health infrastructure - similar steps were successful in leading to the rapid decrease in rates of drug resistance among tuberculosis isolates. With refinements based on local resource constraints, urgent measures could potentially arrest the alarming increase in multidrug-resistant and extensively drug-resistant tuberculosis cases in South Africa. Unlike many countries in sub-Saharan Africa, South Africa has the capacity to mount a rapid and large-scale response before drug-resistant tuberculosis envelops a much larger and far poorer region.

UR - http://www.scopus.com/inward/record.url?scp=43949087247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43949087247&partnerID=8YFLogxK

U2 - 10.1086/587903

DO - 10.1086/587903

M3 - Article

C2 - 18426372

AN - SCOPUS:43949087247

VL - 46

SP - 1729

EP - 1732

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 11

ER -